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Abstract Providing cattle a more bioavailable zinc (Zn)
source prior to administering a beta adrenergic agonist
(βAA) may enhance the metabolic pool of primary nutrients
that will influence the magnitude of the βAA response. Calf-
fed Holstein steers were supplemented with a Zn methionine
supplement (ZnMet; ZINPRO®; Zinpro Corporation, Eden
Prairie, MN) for 115±5 days prior to harvest along with
zilpaterol hydrochloride (ZH; Zilmax®; Merck Animal
Health, Summit, NJ) for the last 20 days with a 3-day with-
drawal to evaluate the effects on growth and carcass perfor-
mance together with gene and protein expression of skeletal
muscle, adipose tissue, and fatty acid composition of polar and
neutral lipid depots. Steers (n=1296; initial weight=468.5±
0.5 kg) were sorted by weight, blocked by harvest date, and
randomly assigned to pens (n=12) and treatments: control
(90 ppm Zn from ZnSO4) and ZnMet (Control plus 720 mg
Zn from ZnMet/hd/d). There were no differences (P>0.05) in
growth performance or carcass characteristics. The ZnMet-fed
cattle had reduced (P<0.05) abundance of myosin heavy
chain (MHC)-IIX, β1-adrenergic receptor (βAR), peroxi-
some proliferator-activated receptor gamma, and stearoyl-
CoA desaturase mRNA in skeletal muscle tissue. The
ZnMet cattle had greater (P<0.05) abundance ofMHC-II pro-
tein, increased MHC-IIA and IIX cross-sectional areas
(P<0.05), an increased percentage of MHC-I fibers
(P<0.05), and a decreased percentage of MHC-IIX fibers
(P<0.05). The combination of ZnMet and ZH had positive
biological effects on musculoskeletal tissue; however, these
molecular effects were not significant enough to impact over-
all feedlot and carcass performance.
Keywords β-Adrenergic receptor . Myosin heavy chain .
Zilpaterol hydrochloride . Zincmethionine
Introduction
Organic complexes of Zn, such as Zn methionine (ZnMet)
have been shown to possess greater bioavailability than inor-
ganic Zn forms such as Zn oxide (ZnO) or Zn sulfate (ZnSO4)
[23]. Spears [24] reported that ZnO and ZnMet are absorbed
to a similar extent but are metabolized differently following
absorption. Lambs supplemented with ZnMet had greater re-
tention of Zn and nitrogen compared to lambs supplemented
with ZnO [24]. Zinc methionine has been reported to increase
growth and feed efficiency in ruminant animals [25].
Furthermore, ZnMet has reportedly improved carcass quality,
increasing the percentage of cattle that grade USDA choice [3,
6, 21].
Zilpaterol hydrochloride (ZH) is a beta adrenergic agonist
(βAA), approved for use in cattle under the trade name of
Zilmax® (Merck Animal Health, Summit, NJ), and is fed at
a rate of 6.8 g/ton (100% DM) for the last 20 to 40 days of the
finishing phase with a 3-day withdrawal prior to slaughter
[19]. Zilpaterol HCl has been documented to improve feed
to gain (F:G), hot carcass weight (HCW), and dressing per-
centage when administered orally to cattle [26, 29].
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Zilpaterol HCl primarily binds with the beta 2 adrenergic
receptor (β2AR), which is the most predominant beta adren-
ergic receptor (βAR) found in cattle muscle and adipose tissue
[12, 13]. Via a secondary messenger signal cascade event,
cyclic adenosine monophosphate (cAMP) is activated thereby
resulting in protein accretion and lipid catabolism [12, 13].
The β2AR potentially has multiple allosteric binding sites
for Zn [12, 27]. It has been suggested that there are two main
binding sites for Zn on the βAR [28]; one affects the agonist’s
ability to bind to the receptor, while the other affects the an-
tagonist’s ability to bind to the receptor thus increasing cAMP
production.
Therefore, providing feedlot cattle with a greater amount of
ZnMet prior to administering ZH may provide a greater met-
abolic pool of primary nutrients that will elicit a greater bio-
logical response from the ZH, especially in skeletal muscle
tissue. The objective of this study was to determine the effect
of supplementing ZnMet (ZINPRO®; Zinpro Corporation,
Eden Prairie, MN) and ZH on feedlot growth performance,
carcass characteristics, skeletal muscle and adipose tissue
gene expression, protein synthesis, and fatty acid composition
of calf-fed Holstein steers.
Materials and Methods
The Institutional Animal Care and Use Committee’s approval
was not needed for this study, as animals were fed offsite from
Texas Tech University at a commercial beef cattle feed yard
and harvested at a USDA inspected commercial abattoir [1].
Animals and Management
Holstein steers (n=1296; 481.5±0.5 kg) were sourced in
southern California and fed in a commercial feed yard prior
to study initiation. Initial processing of steers occurred upon
arrival, and cattle were subjected to vaccination and manage-
ment practices in accordance with the feedlot protocols. Initial
processing procedures were typical for Holsteins fed in the
Southwest USA.
Finishing rations were formulated to meet or exceed the
National Research Council [14] requirements for growing
and finishing beef cattle. Ingredient composition of the finish-
er diets is shown in Table 1. Treatment diets were fed ad
libitum throughout the study.
Complete ration composition profiles were obtained
throughout the study (Table 2). Individual ration samples were
sent to Michigan State University (Lancing, MI) for analyses.
Ration samples were analyzed for moisture, crude protein
(CP), acid detergent fiber (ADF), calcium (Ca), phosphorus
(P), potassium (K), and Zn (Table 2). Pens were observed
daily by trained personnel to identify and remove steers with
observable signs/symptoms of health and/or lameness issues.
Experimental Design and Treatments
Steers were randomized to pens by receiving lot at the time of
terminal steroidal implant administration. Each lot was sorted
by body weight (BW) to form two pens (one pen/treatment)
and blocked by harvest date. A total of 12 pens (n=108
head/pen) were utilized and served as experimental unit. Pens
(n=12) were randomly assigned to one of two treatments: 1)
90 ppm Zn from ZnSO4 (CON; n=6 pens) or CON plus
720 mg/steer/day of Zn from ZINPRO (ZnMet; n=6 pens).
Treatment diets were administered on the final 115±5 days of
the finishing period. Zilpaterol HClwas fed for the final 20 days
with a 3-day withdrawal prior to shipping and slaughter. Upon
trial initiation, steers were weighed individually (initial BW
was reduced by 4 % to represent a standard industry shrink).
Harvest and Carcass Evaluation
Prior to shipment to the abattoir, steers were weighed by pen
on a platform scale (final BWwas reduced by 4% to represent
a standard industry shrink). Steers were transported 35 km to a
nearby commercial abattoir and subsequently harvested under
USDA-FSIS inspection. Pens of cattle were maintained as lots
when presented for harvest.
Carcasses were chilled approximately 36 h prior to grading.
Individual carcass measurements included HCW, dressing
percentage (DP), loin muscle area (LMA), and marbling score
(MS) and were determined via a digital camera grading sys-
tem. Yield grade (YG) and quality grade (QG) information
was recorded as assigned by USDA graders. Dressing per-
centage for each pen was calculated as the mean HCW/





Ingredient (%) Diet 1a Diet 2a
Sudan hay 7.54 7.66
Bakery waste 8.17 8.30
Steam flaked corn – 57.24
Flaked wheat 60.72 –
Wheat straw 2.45 2.49
Liquid urea – 0.64
Dried distillers grain 9.91 13.43
Fat, yellow grease 5.88 4.78
Supplement 5.33 5.46
Diets were formulated to meet or exceed
NRC (1996) requirements for growing–
finishing beef cattle
Diets contained 6.8 g/t zilpaterol hydro-
chloride (Zilmax: Merck, Summit, NJ)
when fed for the final 20 days of the
finishing period
a Diet 1 was fed for 174 days, and Diet 2
was fed for 38 days
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Collection of Skeletal Muscle and Adipose Tissue
Steers (n=40; 20 steers/treatment) were randomly selected for
biochemical analysis of muscle and adipose tissue. Muscle
and adipose tissue were collected from the semimembranosus
muscle of carcasses within 45 min of harvest. The pre-rigor
semimembranosus tissue sample was cut into thirds. For im-
munohistochemical analysis, one cut of the samples was
placed in a clear frozen section compound (VWR
International, Randor, PA), frozen using dry ice-chilled 2-
methyl-butane and then placed in a cooler of dry ice. The other
two cut samples were placed into a whirl-pack for RNA, pro-
tein analysis, and fatty acid analysis, flash frozen in liquid
nitrogen, and placed in a cooler of dry ice. The adipose tissue
was cut in half and placed in a whirl-pack bag for either RNA
or protein analysis, flash frozen, and placed in a cooler of dry
ice. Samples were then shipped to Texas Tech University for
analysis and were subsequently stored in −80 °C freezer until
analysis.
RNA Isolation and Real-Time Quantitative Reverse
Transcription Polymerase Chain Reaction
Ribonucleic acid from muscle and adipose tissue was isolated
with ice-cold buffer containing TRI Reagent® (Sigma, St.
Louis, MO). Approximately 1.5 g of frozen tissue was ho-
mogenized with TRI Reagent® at a ratio of 0.5:1 grams of
tissue to milliliter reagent. The homogenate was then pipetted
into two microcentrifuge tubes (1 mL sample per tube),
200 μL chloroform was added to each tube, vortexed for
30 s, and incubated for 5 min The sample was then centrifuged
at 15,000×g for 15min separating the sample into three layers.
The top supernatant layer was pipetted off and placed into new
microcentrifuge tubes. Ice-cold isopropyl alcohol (250 μL)
was added to the supernatant, shaken, and incubated for
10 min at 25 °C. The samples were then centrifuged at 15,
000×g for 10 min. The supernatant was poured off, the RNA
pellet at the bottom of each tube were allowed to dry, and
500 μL of 75 % ethanol was added to each tube to rinse and
suspend the RNA pellet. Samples were then placed in a
−80 °C freezer until needed (no longer than 3 months).
Samples were then removed from the freezer and thawed on
ice. Samples were then centrifuged at 15,000×RPM for
10 min, ethanol was poured off, and the pellet was air dried.
Nuclease-free water (30 μL) was then added to each sample to
dissolve the RNA pellet. The concentration of RNA was de-
termined with a spectrophotometer at an absorbance of
260 nm using a NanoDrop 1000 (NanoDrop products,
Wilmington, DE). Samples were then treated with DNAse to
remove any DNA contaminants using a DNA-free kit (Life
Table 2 Calculated nutrient and
laboratory analysis of diet
samples
Diet designation
Nutrient Formulated CON Finishinga ZnMet Finishingb
Dry matter (%) 83.5 86.60 85.40
Crude protein (%) 13.3 15.80 15.70
Acid detergent fiber (%) – 10.00 10.90
Neutral detergent fiber, (%) – 19.00 20.80
Calcium (%) 0.74 0.96 0.85
Phosphorus (%) 0.41 0.45 0.43
Magnesium (%) 0.25 0.25 0.25
Potassium (%) – 1.02 1.00
Sodium (%) – 0.28 0.29
Sulfur (%) 0.24 0.27 0.26
Iron (ppm) – 317 352
Zinc (ppm) 94/160c 122 163
Copper (ppm) 23 28 28
Manganese (ppm) 61 77 72
Molybdenum (ppm) - 1.00 1.20
Cobalt (ppm) 0.70 1.40 1.30
Selenium (ppm) 0.40 0.60 0.59
Iodine (ppm) 0.80 1.10 1.14
Samples analyzed by Forage Testing Laboratory, Ithaca, NY, except for Se and I which were analyzed by
Michigan State University, Diagnostic Center for Population and Animal Health
a CON: Control 90 ppm Zn added from ZnSO4
b ZnMet: Control plus 720 mg Zn added from ZINPRO® zinc methionine
c Formulated Zn levels for CON and ZnMet diets, respectively
Zinc Methionine and Skeletal Muscle Growth 317
Technologies, Grand Island, NY). The RNAwas then subject-
ed to reverse transcription to produce cDNA. The cDNAwas
then used for real-time quantitative reverse transcription-PCR
(RT-qPCR) to measure the abundance of AMP-activated pro-
tein kinase alpha (AMPKα) , beta 1 adrenergic receptor
(β1AR), beta 2 adrenergic receptor (β2AR), and beta 3 ad-
renergic receptor (β3AR), myosin heavy chain (MHC)-I,
MHC-IIA, MHC-IIX, C-enhancer binding protein beta
(CEBPβ), G protein-coupled receptor 43 (GPR43), G
protein-coupled receptor 41 (GPR41), glucose transporter
type 4 (Glut4), peroxisome proliferator-activated receptor
gamma (PPARγ), and stearoyl-CoA desaturase (SCD)
mRNA relative to the abundance of ribosomal protein subunit
9 (RPS9) mRNA in total RNA isolated from muscle tissue.
Real-time qPCR was used to measure the abundance of
AMPKα, β2AR, GPR43, GPR41, Glut4, SCD, CEBPβ,
and PPARγ mRNA relative to the abundance of RPS9
mRNA in total RNA isolated from adipose tissue. Bovine
primers and probes for AMPKα, β1AR, β2AR, β3AR,
MHC-I, MHC-IIA, MHC-IIX, GPR43, GPR41, Glut4, SCD,
CEBPβ, and PPARγ are presented in Table 3. Assays were
performed in the GeneAmp 7900HT Sequence Detection
System (Applied Biosystems, Life Technologies) using ther-
mal cycling parameters recommended by the manufacturer
(40 cycles of 15 s at 95 °C and 1 min at 60 °C).
Protein Extraction, Western Blots, and SDS-PAGE Gel
Electrophoresis
Protein from muscle was isolated with whole muscle extrac-
tion buffer (WMEB; 2 % sodium dodecyl sulfate, 10 mM
phosphate, pH 7.0). Adipose tissue protein was isolated with
an ice-cold buffer containing tissue protein extraction reagent
(T-PER; Fisher Scientific, Fair Lawn, NJ), protein inhibitor
(Roche, Branchburg, NJ), and 2 mM Na3VO4 (Fisher
Scientific) at a 1:5 ratio. The homogenized samples were cen-
trifuged at 15,000×g for 15 min, separating the sample into
three layers. The middle supernatant layer was pipetted off
and placed into microcentrifuge tubes. The protein samples
were then diluted with either T-PER or WMEB to determine
protein concentration using the Pierce™ BCA™ protein assay
(Thermo Fisher Scientific, Fairlawn, NJ). Protein concentra-
tion was then determined using a NanoDrop 1000 spectropho-
tometer at 562 nm. All samples were then diluted to the same
concentration. Modified Wang’s tracking dye was added to
western blot samples, and MHC tracking dye was added to
sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE) samples. Samples were denatured with β-
mercaptoethanol and incubated for 2 min at 95 °C. Samples
for western blots were then loaded onto Novex 4–12 % Bis-
Tris gels (Invitrogen, Grand Island, NY), and protein was
separated by gel electrophoresis. The gels were run for ap-
proximately 35 min at 165 V and 27 mA. Proteins were
transferred onto a nitrocellulose membrane (Invitrogen) for
7 min. Following transfer, the membrane was incubated with
non-fat dry milk (BIO RAD, Hercules, CA), 10 % 10 × tris-
buffered saline (TBS) in NanoPure water for 1 h at 25 °C to
block non-specific antibody binding. The blocking solution
was then removed from the membrane. The appropriate pri-
mary antibodies 1:1000 α-beta 1 AR, rabbit, IgG (abcam®,
Cambridge, MA); 1:1000 α-beta 2 AR, goat, IgG (abcam);
and 1:1000α-beta 3 AR, goat, IgG (abcam) were mixed into 1
× TBS-Tween solution, added to the membrane and allowed
to incubate for 2 h (β1AR) or 1 h (β2AR andβ3AR) at 25 °C.
The membrane was then rinsed three times for 10 min in TBS-
Tween. The appropriate Alexa fluorescent antibodies goat α-
rabbit, IgG, Alexa-Fluor 633 (Invitrogen) and donkey α-goat,
IgG, Alexa-Fluor 633 (Invitrogen) were then added at a dilu-
tion of 1:2000 in TBS-Tween to the membrane and incubated
for 1 h at 25 °C in the absence of light. The membranes were
then rinsed three times for 10 min in TBS-Tween in unlighted
conditions. The membranes were then dried and visualized
using the Imager Scanner II and ImageQuant TL programs.
Densitometry measurements were made on the bands corre-
sponding to β1AR, β2AR, and β3AR using a molecular
weight standard for reference (Precision Plus Protein™ All
Blue Standards; BIO RAD).
For SDS-PAGE, 6 % acrylamide separating gels with 4 %
acrylamide stacking gels weremade and set at 4 °C for 4–24 h.
Samples were then loaded onto the gels, and protein was sep-
arated by gel electrophoresis. The gels were run for approxi-
mately 72 h at 100 V. The gel was placed in 300 mL
Coomassie® Fluor Orange (Life Technologies) for 30 min at
25 °C in an opaque container. The Coomassie Fluor Orange
was drained off the gel, and the gel was briefly rinsed in 7.5 %
acetic acid followed by NanoPure water. The gels were then
visualized using the Imager Scanner II and ImageQuant TL
programs. Densitometry measurements were made on the
bands corresponding to MHC-II and MHC-I.
Immunohistochemical Analysis
Twenty-four hours prior to sectioning, embeddedmuscle sam-
ples were moved from −80 to a −20 °C freezer to thaw.
Muscle fiber distribution, area, β-adrenergic receptor, and sat-
ellite cell abundance were determined on 10-μm thick cross
sections. The sections were cut at −20 °C using a Leica
CM1950 cryostat (Lieca Biosystems, Buffalo Grove, IL) from
the embedded muscle samples. The sections were then
mounted on positively charged glass slides (five slides per
sample/three cryosections per slide; Superfrost Plus; VWR
International). Cryosections were fixed using 4 % paraformal-
dehyde (Thermo Fisher Scientific) for 10 min at 25 °C follow-
ed by two brief rinses and a single 5-min rinse in phosphate
buffered saline (PBS). Cryosections were incubated with 5 %
horse serum (Invitrogen), 2 % bovine serum albumin (MP
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Table 3 Sequence of bovine-
specific PCR primers and
TaqMan probes to be used for
determination of expression of
mRNA of AMPKα, MHC-I,
MHC-IIA, MHC-IIX, β1AR,
β2AR, β3AR, CEBPβ, GPR43,
GPR41, Glut4, PPARγ, SCD,
and RPS9
Primer Sequence (5′ to 3′)
















































SCD (accession no. AB075020)
Forward TGCCCACCACAAGTTTTCAG
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Biomedical, Solon, OH), and 0.2 % Triton-X100 (Thermo
Fisher Scientific) in PBS for 30 min at 25 °C to block non-
specific antibody binding. Cryosections were then incubated
for 1 h at 25 °C in the following primary antibodies: slide 1,
1:100 α-dystrophin, rabbit, IgG (Thermo Scientific); 1:100
superna t an t an t i -MHC type 1 , IgG2b (BA-D5;
Developmental Studies Hybridoma Bank, University of
Iowa, Iowa City, IA); and supernatant anti-MHC (all but type
IIX IgG1; BF-35, Developmental Studies Hybridoma Bank);
slide 2, 1:750 α-beta 1 AR, rabbit, IgG (abcam); 1:750 α-beta
2 AR, chicken, IgY (abcam); 1:500 α-beta 3 AR, goat, IgG
(abcam); slide 3, 1:10 supernatant anti-paired box protein 7
(Pax7), mouseα-chicken (Developmental Studies Hybridoma
Bank); 1:100 myogenic factor 5 (Myf-5), rabbit, IgG (Santa
Cruz Biotechnology, Dallas, TX). Slides were then rinsed
three times for 5 min in PBS. Cryosections were incubated
for 30 min at 25 °C in opaque boxes in the following second-
ary antibodies: slide 1, 1:1000 goatα-rabbit, IgG, Alexa-Fluor
488 (Invitrogen); 1:1000 goat α-mouse, IgG1, Alexa-Fluor
546 (Invitrogen); 1:1000 goat α-mouse, IgG2b, Alexa-Fluor
633 (Invitrogen); slide 2, 1:1000 goat α-chicken, IgY, H & L,
Alexa-Fluor 488 (abcam); 1:1000 donkey α-rabbit, IgG,
Alexa-Fluor 546 (Invitrogen); 1:1 000 donkey α-goat, IgG,
Alexa-Fluor 633 (Invitrogen); slide 3, 1:1000 goat α-rabbit,
IgG, Alexa-Fluor 488 (Invitrogen); 1:1000 goat α-mouse,
IgG1, Alexa-Fluor 546 (Invitrogen). Slides were then rinsed
three times for 5 min in PBS. Finally, cryosections were incu-
bated in 1 μg/mL 4′,6-diamidino-2-phenylindole (DAPI,
Thermo Fisher Scientific) for 1 min followed by two brief
PBS rinses. Slides were cover-slipped with mounting media
(Aqua Mount; Lerner Laboratories, Pittsburgh, PA) and thin
glass cover slips (VWR International), and dried at 4 °C for
24 h. All slides were imaged within 48 h of staining.
The slides were imaged at ×200 working difference mag-
nification using an inverted fluorescence microscope (Nikon
Eclipse, Ti-E; Nikon Instruments Inc., Mellville, NY)
equipped with a UV light source (Nikon Intensilight Inc.; C-
HGFIE). The images were captured by a CoolSnap ES2
monochrome camera and artificially colored and analyzed
using the NIS Elements® Imaging software.
Five random images were taken of cryosections from each
slide of the semimembranosus tissue. All MHC type I, IIA,
and IIX muscle fibers in each image were identified and
expressed as a percentage of the total number of muscle fibers.
The cross-sectional area of each fiber in each image was mea-
sured using the NIS Elements software (Nikon Instruments
Inc.) and expressed on a square millimeter basis. The total
number of DAPI-stained cells in each image were enumerated
to determine the nuclear density on a per square millimeter
basis. All βAR, Pax7, Myf5, and, Pax7+Myf5 satellite cells
were identified on the respective slides stained for them,
counted, and densities are reported on a square mm basis.
Beta-adrenergic receptors were classified as βAR or internal-
ized βAR. Classification was determined by the location of
the stained receptors on the fiber cross-section. Receptors lo-
cated on sarcolemma were considered normal βAR, and the
receptors located within the fiber cross-section were consid-
ered internalized βAR.
Fatty Acid Analysis
Fatty acids (FA) were determined for the polar (PL) and neu-
tral lipids (NL) of each muscle tissue sample [9]. Muscle tis-
sue was cubed, flash-frozen in liquid nitrogen, and homoge-
nized into fine powder. All tissue homogenates were stored at
−80 °C until subsequent analysis. Total lipids were extracted
from 0.5-g tissue homogenates by a chloroform:methanol ex-
traction [2]. Extracted lipids were fractionated using a
Resprep® silica gel cartridge (Restek Corporation,
Bellefonte, PA), where NL were initially eluted with chloro-
form, and PL were subsequently eluted with methanol [7].
Fatty acids of the NL were saponified and derivatized to fatty
acid methyl esters (FAME) using sodium methoxide in meth-
anol [10]. Saponification and derivatization of PL FA was
carried out with methanolic potassium hydroxide [11].
Tridecanoic acid methyl ester (CAS# 1731-88-0, Sigma-
Table 3 (continued)
Primer Sequence (5′ to 3′)
Reverse GCCAACCCACGTGAGAGAAG
TaqMan probe 6FAM-CCGACCCCCACAATTCCCG-TAMRA




AMPKαAMP-activated protein kinase alpha,MHC-Imyosin heavy chain-I,MHC-IIAmyosin heavy chain-IIA,
MHC-IIXmyosin heavy chain-IIX, β1AR beta 1 adrenergic receptor, β2AR beta 2 adrenergic receptor, β3AR beta
3 adrenergic receptor, CEBPβ C-enhancer binding protein beta, GPR43 G-protein coupled receptor 43, GPR41
G-protein coupled receptor 41, Glut4 glucose transporter type 4, PPARγ peroxisome proliferator-activated re-
ceptor gamma, SCD stearoyl-CoA desaturase and RPS9 ribosomal protein S9
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Aldrich) was used as the internal standard during derivatiza-
tion. Analysis of FAME was carried out by an Agilent
Technologies (Santa Clara, CA) 7890 gas chromatograph
equipped with an HP-88 capillary column (30 m×250 μm×
0.2 μm; Agilent Technologies, Santa Clara, CA) and a flame
ionization detector. Identity of FAME was determined by
comparison with authentic FAME standards (Supelco® 37
Component FAME Mix, Sigma-Aldrich, St Louis, MO) and
quantified by an internal standard calibration. Individual FA
were calculated as milligram per gram of muscle tissue. FA
were added to calculate the total FA concentration (mg/g mus-
cle tissue) of each fraction and the entire FA composition.
Percentages of FAwere determined by dividing the individual
FA concentration (mg/g muscle tissue) by the corresponding
total FA concentration (mg/g muscle tissue) then multiplying
by 100. Percentages of NL and PL fractions were calculated
by dividing the lipid fraction concentrations (mg/g muscle
tissue) by the total FA concentration (mg/g muscle tissue).
Statistical Analysis
Performance and carcass data were analyzed using the
GLIMMIX procedure of SAS (v.9.3, SAS Institute; Carey,
NC). The model included block as a random effect, and treat-
ment served as a fixed effect. Pen served as the experimental
unit for feedlot performance and carcass characteristics. Initial
weight was used as a covariate. Treatment means were sepa-
rated using the LSMEANS procedure with PDIFF option and
considered different at P<0.05. Tendencies for differences
among treatment means were declared when 0.05>P≤0.10.
Yield grade and quality grade distributions were analyzed
using the FREQUENCY procedure of SAS using the chi-
square option.
For all biochemical analysis, data were analyzed using the
GLIMMIX procedure of SAS (v.9.3, SAS Institute; Carey,
NC). The model included treatment as the fixed effect, steer
served as the experimental unit, and the Kenward-Roger ad-
justment was used to correct degrees of freedom. Means were
separated using the LSMEANS procedure with the PDIFF
option and considered different when P≤0.05. Tendencies
for differences among treatment means were declared when
0.05>P≤0.10.
Results and Discussion
There were no differences (P>0.05; Table 4) in starting and
final weights, dry matter intake (DMI), average daily gain
(ADG), and feed to gain ratios. Spears [24] reported differ-
ences in weight of heifers supplemented with ZnO or ZnMet
when compared to control. However, when ZnO and ZnMet
were supplemented to lambs, ADG and F:G were improved
with Zn supplementation [24]. Zinc methionine has been
reported to increase rate of gain and feed efficiency of heifers
[25]. Greene [3] and Rust [21] reported no difference in gain
or feed efficiency when steers were supplemented ZnO or
ZnMet. In a more recent study, the addition of Zn on ADG
in heifers was unaffected [6]. However, there was an interac-
tion between Zn and implant when Zn was supplemented to
heifers and steers [6]. In the heifers, ADG was 26 % greater in
non-implanted heifers fed with ZnMet than implanted heifers
fed with ZnMet [6]. When ZnSO4 was the supplemented Zn
source, it did not have an effect on ADG, and the implanted
heifers had a greater ADG regardless of ZnSO4 supplementa-
tion [6]. When steers were implanted and supplemented a Zn
source, the results were different [6]. Implant improved ADG
in steers fed with a control diet or supplemented with ZnSO4,
but did not affect ADG of implanted steers supplemented with
ZnMet [6]. Furthermore, in the current study, there was no
difference (P>0.05; Table 5) in HCW, DP, LMA, MS, and
YG between the ZnMet and CON cattle. There were no dif-
ferences between YG and QG distributions (P>0.05; Table 6).
Greene et al. [3] reported that ZnMet increased the percent of
kidney, pelvic and heart fat, MS, and overall QG and tended to
increase backfat thickness. Rust [21] reported that steers sup-
plemented with ZnMet graded 47 % USDAChoice compared
to control at 37 %, and Greene et al. [3] reported ZnMet steers
graded 79 % USDA Choice compared to control at 57 % and
ZnO at 40%.While our distributions were not significant (P=
0.134), 4 % of ZnMet supplemented steers graded USDA
Prime compared to the 1 % of CON. Huerta et al. [6] reported
that heifers supplemented ZnMet graded 70 % USDA Choice
compared to 50 % USDA Choice in control heifers and 30 %
USDA Choice in ZnSO4 heifers. However, there were no
differences in carcass grades or other carcass characteristics
Table 4 Effect of zinc methionine complex in combination with
zilpaterol hydrochloride on growth performance of calf-fed Holstein
steers
CONa ZnMetb SEMc P value
Start (wt, kg) 482 481 3.54 0.837
Final (wt, kg) 618 615 4.81 0.634
Pen start (wt, kg) 52057 51974 382.63 0.838
Pen final (wt, kg) 65539 65425 1041.42 0.916
Mortality, n 3 1 0.88 0.309
DOF 114 114 0.45 0.602
DMI (kg) 8.38 8.40 0.04 0.666
ADG (kg) 1.14 1.16 0.04 0.750
F:G 7.61 7.34 0.33 0.465
G:F 0.13 0.13 0.01 0.638
a CON: Control 90 ppm Zn added from ZnSO4 (n=6 pens).
b ZnMet: Control plus 720 mg Zn added from ZINPRO® zinc methionine
(n=6 pens).
c Pooled standard error of the mean
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of steers supplemented with ZnMet or ZnSO4 [6]. To our
knowledge, no other published literature has evaluated the
effects of ZnMet supplementation and ZH feeding in beef
cattle.
In the semimembranosus tissue, ZnMet cattle contained a
greater abundance of MHC-I mRNA (P<0.05; Table 7) and
tended to have a greater abundance of β2AR mRNA
(P<0.10; Table 7). The ZnMet-supplemented cattle had a low-
er (P<0.05) abundance of MHC-IIX and β1AR mRNA.
Peroxisome proliferator-activated receptor gamma and SCD
mRNA abundance were greater (P<0.05) in CON cattle.
There were no changes (P>0.05; Table 7) in AMPKα,
MHC-IIA, β2AR, β3AR, CEBPβ, GPR43, GPR41, and
Glut4 mRNA between treatments. Knobel [8] reported that
ZH increased MHC-IIX in the gluteus medius supporting the
results seen in our CON group. In data collected from our
laboratory in bovine satellite cells treated with 0 μM ZH and
0 μM Zn, 10 μM ZH, 1 μM Zn, or 10 μM ZH and 1 μM Zn,
we discovered that the combination of Zn and ZH 96 h post-
treatment decreased MHC-IIX and tended to increase MHC-I
mRNA abundance [5] reflecting the results of this trial. In
bovine satellite cell culture work, the addition of ractopamine
HCl (RH) and Zn had no effect on β1AR, β2AR, AMPKα,
IGF-1, MHC-I, MHC-IIA, and MHC-IIX mRNA abundance
[4]. Ractopamine HCl is another βAA used in beef and pork
production. Analysis of the adipose tissue in this study re-
vealed a greater abundance of Glut4 mRNA in CON cattle
(P<0.05; Table 8) when compared to ZnMet. Analysis of
AMPKα, β2AR, CEBPβ, GPR43, GPR41, PPARγ, and
SCD revealed no differences (P>0.05) between treatments.
Oh and Choi [15] reported an increase in PPAYγ2 mRNA
expression in bovine intramuscular adipocytes when Zn
sources were added to the differentiation media at a concen-
tration of 50 and 100 μM.
No differences were detected (P>0.05; Table 9) in β1AR,
β2AR, and β3AR protein abundance between treatments in
the semimembranosus tissue. There were also no differences
Table 5 Effect of zinc methionine complex in combination with
zilpaterol hydrochloride on carcass characteristics of calf-fed Holstein
steers
CONa ZnMetb SEMd P value
HCW (kg) 389 388 2.75 0.794
Dress (%) 62.9 63.0 0.53 0.858
Marblingc 475 487 6.83 0.139
LMA (cm2) 82.35 81.83 0.47 0.317
USDAyield grade 2.8 2.8 0.03 0.835
a CON: Control 90 ppm Zn added from ZnSO4 (n=6 pens)
b ZnMet: Control plus 720 mg Zn added from ZINPRO® zinc methionine
(n=6 pens)
cMarbling score 300=slight; 400=small; 500=modest
d Pooled standard error of the mean
Table 6 Effect of zinc methionine complex in combination with
zilpaterol hydrochloride on USDA quality and yield grade of calf-fed
Holstein steers
Grade, % of carcasses CONa ZnMetb SEMc P value
Prime 1.30 4.35 1.70 0.134
Choice 78.39 76.07 2.66 0.423
Select 19.78 18.75 2.38 0.682
No roll 0.52 0.82 0.32 0.396
Yield grade 1 6.13 3.96 1.97 0.322
Yield grade 2 57.90 62.40 2.74 0.161
Yield grade 3 34.96 33.13 3.70 0.642
Yield grade 4 1.20 1.20 0.48 1.000
a CON: Control 90 ppm Zn added from ZnSO4 (n=6 pens)
b ZnMet: Control plus 720 mg Zn added from ZINPRO® zinc methionine
(n=6 pens)
c Pooled standard error of the mean
Table 7 Effect of zinc methionine complex in combination with
zilpaterol hydrochloride on relative mRNA concentrations of AMPKα,
MHC-I, MHC-IIA, MHC-IIX, β1AR, β2AR, β3AR, CEBPβ, GPR43,
GPR41, Glut4, PPARγ, and SCD genes in semimembranosus tissue
Genea CONb ZnMetc SEMd P value
AMPkα 1.746 1.613 0.207 0.525
MHC-I 0.649 1.025 0.166 0.030
MHC-IIA 2.517 2.208 0.438 0.485
MHC-IIX 1.514 1.085 0.165 0.013
β1AR 7.163 3.101 1.457 0.008
β2AR 0.894 1.282 0.194 0.053
β3AR 33.133 41.718 9.752 0.397
CEBPβ 5.670 4.838 1.157 0.476
GPR43 2.391 0.873 1.292 0.247
GPR41 38.694 38.257 16.807 0.979
Glut4 1.035 1.123 0.095 0.363
PPARγ 3.020 1.749 0.540 0.024
SCD 9.745 2.303 3.052 0.019
AMPKα AMP-activated protein kinase alpha, MHC-I myosin heavy
chain-I, MHC-IIA myosin heavy chain-IIA, MHC-IIX myosin heavy
chain-IIX, β1AR beta 1 adrenergic receptor, β2AR beta 2 adrenergic re-
ceptor, β3AR beta 3 adrenergic receptor, CEBPβ C-enhancer binding
protein beta, GPR43 G-protein coupled receptor 43, GPR41 G-protein
coupled receptor 41,Glut4 glucose transporter type 4,PPARγ peroxisome
proliferator-activated receptor gamma, SCD stearoyl-CoA desaturase
a Relative abundance of the AMPKα, MHC-I, MHC-IIA, MHC-IIX,
β1AR, β2AR, β3AR, CEBPβ, GPR43, GPR41, Glut4, PPARγ, and
SCD genes were normalized with the RPS9 endogenous control by using
the change in cycle threshold (ΔCT)
b CON: Control 90 ppm Zn added from ZnSO4 (n=20 steers)
c ZnMet: Control plus 720 mg Zn added from ZINPRO® zinc methionine
(n=20 steers)
d Pooled standard error of the mean
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(P>0.05; Table 9) in β2AR and β3AR protein abundance
between treatments in adipose tissue. These results are sup-
ported by in vitro data from our laboratory, where we found no
difference in β1AR or β2AR protein abundance of cells treat-
ed with ZH and Zn [3]. Furthermore, Harris [4] also reported
no changes in β1AR and β2AR protein abundance of cells
treated with RH and Zn. Zinc methionine cattle had greater
(P<0.05; Fig. 1) MHC-II protein abundance than CON. The
MHC-II protein abundance includes type IIA and IIX. In ad-
dition, ZnMet cattle had an increased fiber cross-sectional area
of MHC-IIA and IIX fibers (P<0.05; Fig. 2). There was no
difference (P>0.05; Fig. 1) in MHC-I protein abundance and
fiber cross-sectional area (P>0.05; Fig. 2) between
treatments.
Likewise, ZnMet cattle had a greater percentage of MHC-I
fibers (P<0.05; Fig. 3), and tended to have a greater percent-
age of MHC-IIA fibers (P<0.10; 47.01 vs 47.83 % respec-
tively). Control cattle had a greater percentage of MHC-IIX
fibers (P<0.05; Fig. 3). Zilpaterol HCl has been shown to
increase the percentage of MHC-IIX fibers in the longissimus
lumborum, increase the percentage ofMHC-IIX, and decrease
Table 8 Effect of zinc methionine complex in combination with
zilpaterol hydrochloride on relative mRNA concentrations of AMPKα,
β2AR, CEBPβ, GPR43, Glut4, PPARγ, and SCD genes in subcutaneous
adipose tissue
Genea CONb ZnMetc SEMd P value
AMPkα 0.944 0.895 0.130 0.708
β2AR 0.947 0.866 0.263 0.758
CEBPβ 0.467 0.675 0.231 0.373
GPR43 210.230 356.230 169.240 0.400
Glut4 0.843 0.545 0.136 0.035
PPARγ 0.895 0.999 0.176 0.558
SCD 2.358 2.355 1.016 0.997
AMPKα AMP-activated protein kinase alpha, β2AR beta 2 adrenergic
receptor, CEBPβ C-enhancer binding protein beta, GPR43 G-protein
coupled receptor 43, GPR41 G-protein coupled receptor 41, Glut4 glu-
cose transporter type 4,PPARγ peroxisome proliferator-activated receptor
gamma, SCD stearoyl-CoA desaturase
a Relative abundance of the AMPKα, β2AR, CEBPβ, GPR43, GPR41,
Glut4, PPARγ, and SCD genes were normalized with the RPS9 endog-
enous control by using the change in cycle threshold (ΔCT)
b CON: Control 90 ppm Zn added from ZnSO4 (n=20 steers)
c ZnMet: Control plus 720 mg Zn added from ZINPRO® zinc methionine
(n=20 steers)
d Pooled standard error of the mean
Table 9 Effect of zinc methionine complex in combination with
zilpaterol hydrochloride on relative protein concentration of β1AR,
β2AR, and β3AR in semimembranosus and adipose tissue
Receptor CONa ZnMetb SEMc P value
Semimembranosus
β1 3435 3311 109.34 0.266
β2 31,924 32,008 1018.98 0.934
β3 9235 9612 461.14 0.418
Adipose
β2 36,354 36,198 1429.45 0.913
β3 35,159 34,662 1027.68 0.631
a CON: Control 90 ppm Zn added from ZnSO4 (n=20 steers)
b ZnMet: Control plus 720 mg Zn added from ZINPRO® zinc methionine
(n=20 steers)


































Fig. 1 Effect of zinc methionine complex in combination with zilpaterol
hydrochloride on relative protein concentration of myosin heavy chain
(MHC)-I and II semimembranosus tissue. CON: Control 90 ppm Zn
added from ZnSO4 (n=20 steers). ZnMet: Control plus 720 mg Zn
added from ZINPRO® zinc methionine (n=20 steers). There was no
difference in protein concentration of MHC-I (P=0.322; pooled standard
error of the mean (SEM)=2305.27). There was a significant difference in




































Fig. 2 Effect of zinc methionine complex in combination with zilpaterol
hydrochloride on fiber cross-sectional area, (μm2) in semimembranosus
tissue. CON: Control 90 ppm Zn added from ZnSO4 (n=20 steers).
ZnMet: Control plus 720 mg Zn added from ZINPRO® zinc methionine
(n=20 steers). There was no difference in fiber cross-sectional area of
MHC-I (P=0.353; pooled standard error of the mean (SEM)=89.756).
There was a significant difference in the fiber cross-sectional area of
MHC-IIA (P=0.001; SEM=50.977) and MHC-IIX (P=0.001; SEM=
59.431)
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the percentage ofMHC-I in the gluteus medius [8]. Paulk et al.
[16] reported a linear decrease in the percent of MHC-IIA
fibers as Zn concentration increased in pigs supplemented
with RH and Zn. There was a tendency for the percentage of
MHC-IIX fibers to increase when supplemental Zn was fed in
combination with RH [16].
Cattle not supplemented with ZnMet had the greater den-
sity of nuclei (P<0.05; Table 10) and ZnMet cattle had a
greater density of cells expressing Pax7 (P<0.005;
Table 10). There was no difference in the density of cells
expressing Myf5 and Pax7/Myf5 between treatments
(P>0.05). Knobel [8] reported that ZH supplementation de-
creased nuclei density in the longissimus lumborum, gluteus
medius, and semimembranosus. Zilpaterol HCl did not affect
satellite cell populations in the longissimus lumborum, gluteus
medius, and semimembranosus [8].
When evaluating β1AR, internalized β1AR and internal-
ized β3AR, no differences were detected (P>0.05; Table 11).
Control cattle had a greater density of β2AR (P<0.05), while
ZnMet cattle tended to have a greater density of internalized
β2AR (P<0.10). Furthermore, ZnMet cattle tended to have a
greater density of β3AR (P<0.10). These data indicate com-
bining ZnMet and ZH did not affect growth performance;
however, the combination of these supplements numerically
increased the marbling score and the percentage of cattle that
graded USDA Prime (1.30 and 4.35 %; CON vs ZnMet, re-
spectively). Furthermore, fatty acid concentrations from the
neutral lipid fraction, primarily triglycerides from adipocytes,
were determined to be greater in ZnMet muscle tissue
(P<0.05; Table 12). The slight increases observed in marbling
score and cattle grading USDA Prime, along with increased
concentrations of neutral lipid fatty acids in ZnMet cattle may
be the result of decreased mRNA expression of Glut4 in sub-
cutaneous adipose tissue. The effect of decreased mRNA ex-
pression of SCD in ZnMet cattle affected fatty acid composi-
tion and saturation. Through tabulation of fatty acids as per-
centages (g/100 g total fatty acids), it was determined that
neutral lipid stearic acid (18:0) was greater in ZnMet
(P<0.05; Tables 12 and 13). Meanwhile, oleic acid (18:1)
was increased in CON neutral lipids (P<0.05). These results
are in agreement with SCD expression (Table 7) and show a
direct impact on desaturation of 18:0 to 18:1.
While the mechanisms by which Zn enhances muscle hy-
pertrophy when supplemented with βAA have not been fully
elucidated, there is speculation that β2AR potentially have
multiple allosteric binding sites for Zn [28], allowing ZH to
bind more efficiently to β2AR and elicit a greater effect on
muscle hypertrophy. However, overstimulation of theβAR by
βAA results in receptor desensitization [31, 33]. Receptor
desensitization prompts downregulation of adenylate cyclase
catalytic activity, resulting in a reduction of cAMP synthesis
and protein kinase A activation [32]. When the βAR become
desensitized, they are sequestered within an intracellular ves-






























Fig. 3 Effect of zinc methionine complex in combination with zilpaterol
hydrochloride on muscle fiber type composition in semimembranosus
tissue. CON Control 90 ppm Zn added from ZnSO4 (n=20 steers).
ZnMet Control plus 720 mg Zn added from ZINPRO® zinc methionine
(n=20 steers). There was a significant difference in composition ofMHC-
I (P=0.001; pooled standard error of the mean (SEM)=0.026) andMHC-
IIX (P=0.001; SEM=0.017). There was no difference in the composition
of MHC-IIA (P=0.069; SEM=0.017)
Table 10 Effect of zinc methionine complex in combination with
zilpaterol hydrochloride on nuclei and satellite cell density in
semimembranosus tissue
Item (mm2) CONa ZnMetb SEMc P value
Total nuclei 658.99 596.10 16.902 0.001
Myofiber nuclei 577.58 509.38 16.806 <0.001
Pax7 1.81 3.71 0.669 0.005
Myf5 66.66 70.84 3.245 0.199
Pax7+Myf5 12.92 12.16 1.583 0.628
a CON: Control 90 ppm Zn added from ZnSO4 (n=20 steers)
b ZnMet: Control plus 720 mg Zn added from ZINPRO® zinc methionine
(n=20 steers)
c Pooled standard error of the mean
Table 11 Effect of zinc methionine complex in combination with
zilpaterol hydrochloride on β-adrenergic receptor density in
semimembranosus tissue
Item (mm2) CONa ZnMetb SEMc P value
β1AR 270.84 265.72 9.052 0.572
β1AR-internalized 0.13 0.26 0.189 0.476
β2AR 350.77 308.81 10.537 0.001
β2AR-internalized 0.06 0.61 0.297 0.068
β3AR 120.67 132.66 6.309 0.058
β3AR-internalized 0.06 0.26 0.148 0.175
a CON: Control 90 ppm Zn added from ZnSO4 (n=20 steers)
b ZnMet: Control plus 720 mg Zn added from ZINPRO® zinc methionine
(n=20 steers)
c Pooled standard error of the mean
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pathway [31, 33]. The decreased density of β2AR on the cell
surface and increased density of internalized β2AR in the
ZnMet cattle suggests that the β2AR were desensitized and
sequestered within an intracellular vesicle. The desensitization
of the β2AR may have occurred due to the allosteric binding
of Zn to theβ2AR, increasing the affinity for ZH to bind to the
receptor. While the affinity of the β2AR may have been en-
hanced, the hypothesized positive implications on hypertro-
phy and performance were not observed in this study. Thus,
future research should focus on the relationship in which zinc
alters affinity and its interaction with muscle hypertrophy.
When evaluating the protein abundance ofMHC and cross-
sectional area of the fibers, the ZnMet cattle had a greater
abundance of MHC-II protein and had greater cross-
sectional areas for MHC-IIA and IIX fibers. The ZnMet treat-
ment also increased the percentage of MHC-I and IIA fibers
while decreasing the percentage of MHC-IIX fibers, indicat-
ing that Zn supplementation may alter fiber type by increasing
the percentage of the more oxidative fibers. The mRNA ex-
pression supports the previous statement, as the ZnMet treat-
ment had increased expression of MHC-I and decreased ex-
pression of MHC-IIX. The increase in MHC-II protein con-
centration and MHC-IIA and IIX fiber cross-sectional areas
observed coupled by a decreased percentage of MHC-IIX
fibers in the ZnMet treatment is an interesting phenomenon.
Typically, as fiber cross-sectional area increases, the fiber
types will transition to the more glycolytic fiber types [17,
18]. The ZnMet treatment had a lower density of total and
myofiber nuclei, which was an expected dilution effect with
increases in fiber cross-sectional area. Essentially, the ZnMet
treatment had a greater cross-sectional muscle fiber area being
regulated by fewer nuclei. However, it is important to note that
the total nuclei density reported in this study includes nuclei
associated with the satellite cells. While the ZnMet cattle had
the least total nuclei density, they had the greatest density of
Pax7-expressing satellite cells. The expression of Pax7 is re-
quired for adult muscle satellite cells to form and proliferate
[20, 22], and Pax7 satellite cells still maintain the ability to
proliferate [30]. After proliferation, satellite cells either down-
regulate Pax7 and enter into differentiation or maintain Pax7
and stop expressing myogenic determination factor 1 and re-
vert to a quiescent state [30]. The increased density of Pax7-
expressing satellite cells in the ZnMet treatment suggests that
those animals have the ability to increase the total nuclei and
myofiber nuclei through the proliferation and differentiation
of the Pax7 satellite cells. The ability to increase the myofiber




(mg/g muscle tissue) and
percentages (g/100 g total fatty
acids) of individual neutral lipid
fatty acids (FA) and FA categories
(saturated fatty acids (SFA),
monounsaturated (MUFA), and
polyunsaturated fatty acids
(PUFA)) of neutral and polar lipid
fractions (LF) from
semimembranosus tissue
FA mg/g muscle tissue %, g/100 g total FA
CONa ZnMetb SEMc P value CONa ZnMetb SEMc P value
Total FA 22.084b 34.047a 4.907 0.046
SFA 10.225 16.537 2.285 0.054 45.988b 49.375a 0.945 0.013
14:0 0.832b 1.402a 0.194 0.041 3.745 4.222 0.182 0.061
15:0 0.125 0.198 0.026 0.051 0.589 0.600 0.026 0.766
16:0 5.813 9.333 1.255 0.051 26.130b 28.051a 0.694 0.049
17:0 0.252 0.419 0.062 0.061 1.131 1.213 0.062 0.332
18:0 3.141 5.111 0.759 0.069 14.085b 15.058a 0.539 0.190
23:0 0.013a 0.008b 0.001 0.003 0.076 0.027 0.021 0.054
MUFA 11.044 16.208 2.500 0.142 50.128a 46.635b 0.941 0.010
14:1 0.293 0.464 0.065 0.064 1.304 1.450 0.107 0.320
16:1 0.828 1.253 0.163 0.068 3.721 3.943 0.242 0.499
17:1 0.233 0.364 0.052 0.076 1.049 1.107 0.063 0.501
18:1 trans 1.089b 1.929a 0.269 0.031 5.139 5.545 0.366 0.414
18:1 cis-9 8.469 11.976 1.972 0.204 38.302a 33.911b 1.154 0.009
20:1 0.131b 0.220a 0.027 0.026 0.611 0.678 0.030 0.115
PUFA 0.815b 1.302a 0.161 0.037 3.881 3.992 0.188 0.665
18:2 n-6 0.622b 0.998a 0.123 0.033 2.987 3.058 0.155 0.733
18:3 n-3 0.038b 0.066a 0.008 0.024 0.181 0.200 0.009 0.163
20:3 n-6 0.018 0.028 0.004 0.095 0.085 0.084 0.008 0.966
20:4 n-6 0.041 0.044 0.004 0.605 0.227 0.164 0.035 0.188
Means in the same row having different letters are significant at P≤0.05 due to ZnMet/CON×LF interaction
a CON: Control 90 ppm Zn added from ZnSO4 (n=20 steers)
b ZnMet: Control plus 720 mg Zn added from ZINPRO® zinc methionine (n=20 steers)
c Pooled standard error of the mean
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nuclei implies possible enhancement in muscle hypertrophy in
the ZnMet treatment.
While there is little data on the interactions of Zn source,
βAA, and βAR on growth and the biological process in-
volved in these changes, these compounds have been individ-
ually studied extensively. Previous data reports that ZnMet
supplementation often times increases fat thickness, as well
as MS and QG which may possibly have an economic impact
[3, 6, 21]. However, ZnMet supplementation has been shown
to have varying effects on feedlot performance. Studies have
shown that ZnMet improved ADG and feed efficiency [24,
25], while others have reported no difference in ADG or feed
efficiency [3, 6, 21]. Conversely, ZH supplementation has
consistently been shown to improve feedlot and carcass per-
formance [19, 26, 29, 34]. Studies have reported ZH improved
feed to gain, HCW, dressing percentage, and LMAwhile de-
creasing backfat thickness [19, 26, 29, 34]. While the combi-
nation of ZnMet and ZH had positive effects on the molecular
level (MHC isoforms and cross-sectional area), there were
minimal effects on overall feedlot and carcass performance.
The lack of feedlot and carcass performance in this study may
implicate that the animal was already at its maximum potential
due to ZH supplementation, and may not be capable of
additional growth performance. The mechanisms by which
ZnMet and ZH interact to elicit effects on performance, lipid
metabolism, and myogenic activity is still unknown, and fu-
ture research should be conducted to further elucidate the mo-
lecular mechanisms that impact muscle and adipose metabo-
lism in biological processes involving ZnMet and other
growth promotant technologies.
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